A liver and heart disease being prevented. Viral hepatitis B Cardiovascular disease Non-
Conditions
Interventions
sectional study that will be conducted in the staff from the Chulalongkorn University and King Chulalongkorn Memorial Hospital who have their routine annual health check-
ups
Prevention
Liver and Heart Disease
Sponsors
Department of Biochemistry, Faculty of Medicine, Chulalongkorn University
Faculty of Allied Health Sciences,
Chulalongkorn University
Eligibility
Sex/Gender
All
Age
40 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Currently working at the Chulalongkorn University or King Chulalongkorn Memorial Hospital 2. Provide written informed consent
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of HBV infection, HCV infection, NAFLD, MS, HT and CVD risk. The study duration will be for one year. Blood testing, Transient elastography (TE), RAMA-EGAT and Framingham risk score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Association of HCV infection, NAFLD, and CVD risks and correlation between MS, CVD and NAFLD. The study duration will be for one year. Statistical analysis | — |
Countries
Thailand
Contacts
Public ContactPisit Tangkijvanich
Department of Biochemistry, Faculty of Medicine, Chulalongkorn University
Outcome results
None listed